| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 1P01UJR9X1 |
| InChI Key | BJBCSGQLZQGGIQ-QGZVFWFLSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C19H17ClF3NO4 |
| Molecular Weight | 415.8 |
| AlogP | 4.16 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 7.0 |
| Polar Surface Area | 64.63 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 28.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| MODULATOR | Peroxisome proliferator-activated receptor gamma modulator | PubMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 1
Nuclear hormone receptor subfamily 1 group C
Nuclear hormone receptor subfamily 1 group C member 3
|
7365-12000 | - | - | - | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC22 family of organic cation and anion transporters
|
12000 | - | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Diabetes Mellitus, Type 2 | 2 | D003924 | ClinicalTrials |
| Gout | 2 | D006073 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 24136-23-0 |
| ChEMBL | CHEMBL2103824 |
| DrugBank | DB11811 |
| FDA SRS | 1P01UJR9X1 |
| PubChem | 12082259 |
| SureChEMBL | SCHEMBL3302781 |
| ZINC | ZINC000002012859 |